Lumexa Imaging Holdings, Inc. (LMRI) director discloses major stock option grant

Rhea-AI Filing Summary

Lumexa Imaging Holdings, Inc. disclosed that one of its directors holds a stock option covering 422,222 shares of common stock at an exercise price of $18.5 per share. This statement reflects the director’s beneficial ownership as a single reporting person.

According to the filing, 222,222 shares underlying the option have already vested. The remaining shares will vest in three substantially equal installments on November 27 of 2026, 2027 and 2028, and each installment depends on the director continuing to provide service to the company. This structure ties a large portion of the director’s potential equity interest to ongoing tenure with Lumexa Imaging.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Cooper Henry Lee

Role Director

Type	Security	Shares	Price	Value
holding	Stock Option (right to buy)	--	--	--

Holdings After Transaction: Stock Option (right to buy) — 422,222 shares (Direct)

Footnotes (1)

1. [object Object]

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Cooper Henry Lee

(Last) (First) (Middle)

4200 SIX FORKS ROAD

SUITE 1000

(Street)

RALEIGH NC 27609

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/11/2025

3. Issuer Name and Ticker or Trading Symbol
Lumexa Imaging Holdings, Inc. [ LMRI ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	(1)	12/10/2035	Common Stock	422,222	$18.5	D

Explanation of Responses:

1. 222,222 shares of the Issuer's common stock ("Common Stock") subject to the stock option have vested, and the remaining shares of Common Stock subject to the stock option will vest in three substantially equal installments on November 27 of 2026, 2027 and 2028, subject to the Reporting Person's continued service with the Issuer.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ Julie Szeker, attorney-in-fact	12/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider position is reported for Lumexa Imaging Holdings, Inc. (LMRI)?

The filing shows that a director of Lumexa Imaging Holdings, Inc. is the reporting person. The form is filed by one reporting person and details this director’s beneficial ownership of a stock option over the company’s common stock.

How many Lumexa Imaging (LMRI) shares are covered by the reported stock option?

The director holds a stock option (right to buy) for 422,222 shares of Lumexa Imaging Holdings, Inc. common stock as disclosed in the beneficial ownership table.

What is the exercise price of the Lumexa Imaging (LMRI) stock option?

The filing states that the stock option has an exercise price of $18.5 per share for the underlying shares of Lumexa Imaging Holdings, Inc. common stock.

How much of the Lumexa Imaging (LMRI) stock option has vested so far?

The explanation section notes that 222,222 shares of Lumexa Imaging’s common stock subject to the stock option have already vested as of the event date.

What is the vesting schedule for the remaining Lumexa Imaging (LMRI) option shares?

The remaining shares under the option will vest in three substantially equal installments on November 27 of 2026, 2027 and 2028, and each installment is subject to the director’s continued service with Lumexa Imaging Holdings, Inc.

When does the reported Lumexa Imaging (LMRI) stock option expire?

Table II shows that the director’s stock option has an expiration date of 12/10/2035, after which any unexercised portion would no longer be available.